IPCA Laboratories Limited
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)
What IPCA files
- Others46
- Investor Meet26
- Important21
- Board Meeting11
- Updates9
- Dividend/Bonus8
IPCALAB has set August 7, 2026, as the Record Date for shareholders to be eligible for the Rs. 6/- per share (600%) dividend. This dividend, if sanctioned at the Annual General Meeting on August 13, 2026, will be paid on or before September 10, 2026. Only shareholders registered by the...
Ipca Laboratories' Board has proposed a final dividend of Rs. 6/- per equity share (600%) for the financial year. This significant payout, subject to shareholder approval at the upcoming Annual General Meeting, underscores the company's robust performance. A record date has been set for eligible shareholders. This move is expected...
IPCALAB has announced a record date on August 5, 2025, for shareholders to be eligible for the final dividend of Rs. 2 per share (200%), subject to approval at the Annual General Meeting. The dividend, if approved, will be paid on or before September 10, 2025. No book closure period...
Ipca Laboratories has announced a board meeting approving the financial results for the quarter and half-year. The Board has proposed a final dividend of Rs. 2/- per share (200%), subject to shareholder approval, with a record date set for entitlement. Key performance highlights show strong growth: standalone net income rose...
The company has revised the record date to Wednesday, 27th November 2024 for the entitlement of an interim dividend of ₹2 per share (200%) for the financial year 2024-25. This interim dividend was declared during the board meeting held on 14th November 2024. Shareholders should ensure their holdings are recorded...